It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Learn how online tools can help you efficiently find investment opportunities. Simplify your investment search with technology.
22,540 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Inflation is pushing shoppers to hunt for value, and Target is answering with a broad price-cut program on 3,000 item...
Hims & Hers is set to report Q1 earnings after the close as investors weigh a rebound in shares and the pace of cash ...
AI data centers demand rock-solid power and long-term service, not hype. This boring industrial stock quietly bankrol...
Costco delivered solid quarterly momentum with rising membership revenue, but the stock remains elevated on a high mu...
A ten-day residency in Amsterdam by a global pop star pushed hotel demand and prices higher, with a Gen Zer paying $1...
As mortgage rates hover in a uncertain range, borrowers turn to Credible's marketplace for quick, transparent prequal...
Zillow has filed a federal antitrust lawsuit in Chicago, alleging MRED and Compass coordinated to hide certain listin...
Sui Network’s mainnet went dark for 5 hours and 55 minutes Thursday due to a bug in the 1.72 update. Service was rest...
Rising sales of probiotics and prebiotics are redefining everyday wellness budgets, while investors watch health and ...
A landmark housing bill becomes law without Trump’s signature, signaling a setback for GOP messaging ahead of midterm...
Former BitMEX chief Arthur Hayes reportedly acquired a tranche of ETHFI ahead of Upbit's listing, sparking a price sp...